[1]
R. Ravasio, P. Pisarra, R. Porzio, and M. Comaschi, “Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy”, Grhta, vol. 3, no. 2, pp. 92–101, Jul. 2016.